| Pharmaceutical active ingredients: |
| Insulin Inhalation Human rDNA origin |
| Available forms, composition and doses of Exubera: |
| Powder; Inhalation; Insulin Inhalation Human rDNA origin 1 mgPowder; Inhalation; Insulin Inhalation Human rDNA origin 3 mg |
| Exubera medical category: |
| Human:Insulin preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10AF01 - Insulin (Human) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerNektar Therapeutics |
| Related documents and information about Exubera: |
| Exubera prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Novolin R Recombinant | Insulin Human recombinant; Insulin Human recombinant purified | Novo Nordisk |
| Recosulin-R | Insulin Human recombinant; Insulin Soluble Human Neutral rapid acting recombinant | Shreya Life Sciences |
| Ransulin-R | Insulin Human Regular recombinant | Tonghua Dongbao Pharmaceutical; Endure Medical |
| Huminsulin L | Insulin Human Zinc Suspension Monocomponent | Eli Lilly |
| Lupinsulin 30 / 70 | Insulin Human; Insulin Isophane Human | Multicare Pharmaceuticals Philippines |
| Insulin 2 | Insulin Injection Acid Bovine | Novo Nordisk |
| Hypurin Soluble | Insulin Injection Acid Bovine, highly purified | Wockhardt |
| Rapitar MC | Insulin Injection Biphasic Bovine and Porcine | Novo Nordisk |
| Rapitard | Insulin Injection Biphasic Bovine and Porcine, monocomponent | Novo Nordisk |
| Rapitard MC | Insulin Injection Biphasic Bovine and Porcine, monocomponent | Novo Nordisk |